BioSpace News Archive

He will be responsible for new client acquisition and new plan development.

“Allergic Action” Campaign Creates Awareness of Allergic March & How to Reduce the Impact of Future Allergies

Sun Pharmaceutical Industries Ltd. announced the U.S. launch of Ezallor Sprinkle™ capsules for the treatment of three types of elevated lipid disorders in people who have difficulty swallowing, a problem that is estimated to affect approximately 30-35% of long-term care residents.

Marken announced that they have acquired HRTL based in Italy along with two additional companies in Austria and Hungary under the respective names of HETO and Der Kurier.

POXEL SA announced its cash position and revenue for the second quarter and the first half of 2019.

Masimo announced that in a study recently published in the Journal of Clinical Monitoring and Computing, researchers investigated the ability of Masimo ORi™ to serve as a noninvasive indicator of the arterial partial pressure of oxygen during general anesthesia, to help avoid hyperoxia.1 ORi is an index of oxygenation in the moderate hyperoxic region.

Facility Expansion is Part of a $100M Investment to Enhance the Delivery of Essential Health Innovations to Consumers

Synlogic, Inc., , a clinical stage company developing a novel class of Synthetic BioticTM therapeutics, announced positive top-line clinical data from patient cohorts of a randomized, double-blind, placebo-controlled Phase 1/2a study of SYNB1618, which is being developed for the treatment of phenylketonuria.

New interactive technology is available in-office to cancer patients across the region to deliver a new level of understanding and communication with patients.

Professor Jacky Smith from the University of Manchester to lead live webcast